Literature DB >> 27981648

Elevated skin and core temperatures both contribute to reductions in tolerance to a simulated haemorrhagic challenge.

James Pearson1,2, Rebekah A I Lucas1,3, Zachary J Schlader1,4, Daniel Gagnon1, Craig G Crandall1.   

Abstract

NEW
FINDINGS: What is the central question of this study? Combined increases in skin and core temperatures reduce tolerance to a simulated haemorrhagic challenge. The aim of this study was to examine the separate and combined influences of increased skin and core temperatures upon tolerance to a simulated haemorrhagic challenge. What is the main finding and its importance? Skin and core temperatures increase during many occupational settings, including military procedures, in hot environments. The study findings demonstrate that both increased skin temperature and increased core temperature can impair tolerance to a simulated haemorrhagic challenge; therefore, a soldier's tolerance to haemorrhagic injury is likely to be impaired during any military activity that results in increased skin and/or core temperatures. Tolerance to a simulated haemorrhagic insult, such as lower-body negative pressure (LBNP), is profoundly reduced when accompanied by whole-body heat stress. The aim of this study was to investigate the separate and combined influence of elevated skin (Tskin ) and core temperatures (Tcore ) on LBNP tolerance. We hypothesized that elevations in Tskin as well as Tcore would both contribute to reductions in LBNP tolerance and that the reduction in LBNP tolerance would be greatest when both Tskin and Tcore were elevated. Nine participants underwent progressive LBNP to presyncope on four occasions, as follows: (i) control, with neutral Tskin (34.3 ± 0.5°C) and Tcore (36.8 ± 0.2°C); (ii) primarily skin hyperthermia, with high Tskin (37.6 ± 0.2°C) and neutral Tcore (37.1 ± 0.2°C); (iii) primarily core hyperthermia, with neutral Tskin (35.0 ± 0.5°C) and high Tcore (38.3 ± 0.2°C); and (iv) combined skin and core hyperthermia, with high Tskin (38.8 ± 0.6°C) and high Tcore (38.1 ± 0.2°C). The LBNP tolerance was quantified via the cumulative stress index (in millimetres of mercury × minutes). The LBNP tolerance was reduced during the skin hyperthermia (569 ± 151 mmHg min) and core hyperthermia trials (563 ± 194 mmHg min) relative to control conditions (1010 ± 246 mmHg min; both P < 0.05). However, LBNP tolerance did not differ between skin hyperthermia and core hyperthermia trials (P = 0.92). The lowest LBNP tolerance was observed during combined skin and core hyperthermia (257 ± 106 mmHg min; P < 0.05 relative to all other trials). These data indicate that elevated skin temperature, as well as elevated core temperature, can both contribute to reductions in LBNP tolerance in heat-stressed individuals. However, heat stress-induced reductions in LBNP tolerance are greatest in conditions when both skin and core temperatures are elevated.
© 2016 The Authors. Experimental Physiology © 2016 The Physiological Society.

Entities:  

Keywords:  cutaneous vascular conductance; hyperthermia; simulated hemmorhagic tolerance

Mesh:

Year:  2017        PMID: 27981648      PMCID: PMC5784401          DOI: 10.1113/EP085896

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  18 in total

1.  The contribution of constrictor and dilator nerves to the skin vasodilatation during body heating.

Authors:  I C RODDIE; J T SHEPHERD; R F WHELAN
Journal:  J Physiol       Date:  1957-05-23       Impact factor: 5.182

2.  Interactions between local and reflex influences on human forearm skin blood flow.

Authors:  J M Johnson; G L Brengelmann; L B Rowell
Journal:  J Appl Physiol       Date:  1976-12       Impact factor: 3.531

3.  Sweat loss during heat stress contributes to subsequent reductions in lower-body negative pressure tolerance.

Authors:  Rebekah A I Lucas; Matthew S Ganio; James Pearson; Craig G Crandall
Journal:  Exp Physiol       Date:  2012-08-07       Impact factor: 2.969

4.  Age alters the cardiovascular response to direct passive heating.

Authors:  C T Minson; S L Wladkowski; A F Cardell; J A Pawelczyk; W L Kenney
Journal:  J Appl Physiol (1985)       Date:  1998-04

5.  Cutaneous vascular responses to isometric handgrip exercise.

Authors:  W F Taylor; J M Johnson; W A Kosiba; C M Kwan
Journal:  J Appl Physiol (1985)       Date:  1989-04

6.  Cardiovascular responses to sustained high skin temperature in resting man.

Authors:  L B Rowell; G L Brengelmann; J A Murray
Journal:  J Appl Physiol       Date:  1969-11       Impact factor: 3.531

7.  Cardiovascular changes during syncope induced by tilting men in the heat.

Authors:  A R Lind; C S Leithead; G W McNicol
Journal:  J Appl Physiol       Date:  1968-09       Impact factor: 3.531

8.  Heat stress reduces cerebral blood velocity and markedly impairs orthostatic tolerance in humans.

Authors:  Thad E Wilson; Jian Cui; Rong Zhang; Craig G Crandall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-06-08       Impact factor: 3.619

9.  Elevated local skin temperature impairs cutaneous vasoconstrictor responses to a simulated haemorrhagic challenge while heat stressed.

Authors:  J Pearson; R A I Lucas; C G Crandall
Journal:  Exp Physiol       Date:  2012-08-17       Impact factor: 2.969

10.  Skin cooling aids cerebrovascular function more effectively under severe than moderate heat stress.

Authors:  Rebekah A I Lucas; Philip N Ainslie; Jui-Lin Fan; Luke C Wilson; Kate N Thomas; James D Cotter
Journal:  Eur J Appl Physiol       Date:  2009-11-28       Impact factor: 3.078

View more
  2 in total

1.  Impact of environmental stressors on tolerance to hemorrhage in humans.

Authors:  Craig G Crandall; Caroline A Rickards; Blair D Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-12-05       Impact factor: 3.619

Review 2.  Post-exercise Body Cooling: Skin Blood Flow, Venous Pooling, and Orthostatic Intolerance.

Authors:  Afton D Seeley; Gabrielle E W Giersch; Nisha Charkoudian
Journal:  Front Sports Act Living       Date:  2021-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.